InChI=1S/C30H49N3O2/c1- 18- 11- 22- 15- 29- 30(35,23- 16- 26(22) 27(12- 18) 32(4) 17- 23) 8- 7- 24(31- 29) 14- 21- 10- 19(2) 13- 28- 25(21) 6- 5- 9- 33(28) 20(3) 34/h18- 19,21- 28,35H,5- 17H2,1- 4H3/t18- ,19+,21- ,22+,23- ,24+,25+,26- ,27+,28- ,30+/m1/s1 |
QRIZONDFXOOWTA-MREYPERPSA-N |
[H] [C@] 1(CC[C@] 2(O) [C@H] 3CN(C) [C@H] 4C[C@H] (C) C[C@@] ([H] ) (CC2=N1) [C@@] 4([H] ) C3) C[C@@] 1([H] ) C[C@H] (C) C[C@@] 2([H] ) N(CCC[C@@] 12[H] ) C(C) =O |
|
Bronsted base
A molecular entity capable of accepting a hydron from a donor (Bronsted acid).
(via organic amino compound )
|
|
metabolite
Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
(via alkaloid )
|
|
View more via ChEBI Ontology
(1R,2S,5S,9S,11R,13S,17R)- 5- {[(4aS,5R,7S,8aR)- 1- acetyl- 7- methyldecahydroquinolin- 5- yl]methyl}- 11,14- dimethyl- 6,14- diazatetracyclo[7.6.2.02,7.013,17]heptadec- 6- en- 2- ol
|
(4aS,5R,7S,8aR)- 1- acetyl- 5- [[(2S,4aS,5R,6aR,7S,9R,10aS)- 3,4,4a,5,6,6a,7,8,9,10,10a,11- dodecahydro- 4a- hydroxy- 9,12- dimethyl- 7,5- (iminomethano)- 2H- benzo[5,6]cyclohepta[1,2- b]pyridin- 2- yl]methyl]decahydro- 7- methylquinoline
|
IUPAC
|
Oxolucidine B
|
KEGG COMPOUND
|
Serratanine B
|
KEGG COMPOUND
|
71384-25-3
|
CAS Registry Number
|
ChemIDplus
|
8600822
|
Reaxys Registry Number
|
Reaxys
|
10731030
|
PubMed citation
|
Europe PMC
|
15565253
|
PubMed citation
|
Europe PMC
|
|